Carregant...
Real-world treatment patterns, healthcare resource utilisation and costs in patients with systemic lupus erythematosus treated with belimumab: a retrospective analysis of claims data in the USA
OBJECTIVE: To examine the effects of belimumab initiation on healthcare resource utilisation (HCRU) and costs in SLE. METHODS: This retrospective observational cohort study used healthcare administrative claims data from the IBM MarketScan Commercial Claims and Encounters Database to identify patien...
Guardat en:
| Publicat a: | Lupus Sci Med |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7174061/ https://ncbi.nlm.nih.gov/pubmed/32341790 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/lupus-2019-000357 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|